March 9, 2020 / 12:52 PM / 24 days ago

BRIEF-Algernon Scales Up Manufacturing Of Np-120 (Ifenprodil) To Prepare For Coronavirus And Acute Lung Injury U.S. Clinical Trials

March 9 (Reuters) - Algernon Pharmaceuticals Inc:

* ALGERNON SCALES UP MANUFACTURING OF NP-120 (IFENPRODIL) TO PREPARE FOR CORONAVIRUS AND ACUTE LUNG INJURY US CLINICAL TRIALS

* ALGERNON PHARMACEUTICALS - MADE DECISION TO BEGIN PRODUCTION OF NP-120 (IFENPRODIL) WITH A NEW INJECTABLE AND LONG ACTING ORAL RELEASE FORMULATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below